{
    "2020-06-08": [
        [
            {
                "time": "",
                "original_text": "疫苗行业系列报告之批签发跟踪：疫苗5月批签发数据专题",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "5月",
                        "数据"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年6月投资月报：医药的牛市 是从什么时候开始的？",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "牛市",
                        "投资",
                        "6月"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：全球疫情持续 API和CDMO二季度超预期机会明显",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "疫情",
                        "API",
                        "CDMO",
                        "二季度",
                        "超预期"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "14倍大牛股隐忧：万泰生物HPV疫苗的市场悬疑",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "HPV疫苗",
                        "市场",
                        "悬疑"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}